Erin VanDyke Congratulates IU Health on Joining the NBCA COE Program
Erin VanDyke, PA-C, MPAS, Vice President of National Blood Clot Alliance Centers of Excellence, reposted from NBCA on LinkedIn:
”Congrats to the VTE teams at IU Health and welcome to the National Blood Clot Alliance COE program!!
We are so excited for this partnership and for the VTE excellence this team brings to Indiana.
Great things happen when patients, clinicians, and community come together!
Looking forward to the path forward..together!!
NBCA posted on LinkedIn:
”Great news for blood clot patients in Indiana!
The National Blood Clot Alliance (NBCA) is proud to announce IU Health Methodist Hospital in Indianapolis as the state’s first NBCA Venous Thromboembolism (VTE) Center of Excellence™, joining a growing national network dedicated to excellence in the prevention, diagnosis, and treatment of blood clots.
This recognition reflects the outstanding multidisciplinary efforts across IU Health, including teams at both Methodist and University hospitals. Their collaboration has been instrumental in achieving the high standards required for this designation. As IU Health prepares to integrate these hospitals into a single, state-of-the-art facility, this designation will carry forward — underscoring a continued commitment to excellence in VTE care.
‘This designation reflects our team’s tireless efforts to implement timely diagnosis, appropriate treatment, and long-term prevention strategies for patients at risk of blood clots,’ said Paul Haste, MD. ‘We could not be more excited to partner with NBCA to continue this important work improving care for patients throughout the state of Indiana.’
Congratulations to IU Health Methodist Hospital for this well-deserved honor.”
Stay updated on the latest news in the field of hematology with Hemostasis Today.
-
Sep 18, 2025, 06:50Fetal Hereditary TTP Featured in NEJM – Senior Author Nishant Rajendra Tiwari
-
Sep 17, 2025, 10:54Mitapivat Boosts ATP in Red Cells: Dr. William Aird on New Hope for Hemolytic Disorder
-
Sep 17, 2025, 08:16Superficial Vein Thrombosis Management: John Fanikos Shares Latest Review
-
Sep 17, 2025, 07:00Maha Othman - ''BIC 2025 is Without a Doubt a Remarkable Scientific Event — and I’m Excited for What Lies Ahead!''
-
Sep 16, 2025, 11:17Glenn Pierce: WHO Issues a Biannual Essential Medicines List
-
Sep 18, 2025, 07:00Rishabh Singh on NEJM Letter: FVIII Aurora Mutation Shows Increased Activity and Reduced APC Response
-
Sep 18, 2025, 02:25Flora Peyvandi Highlights 'Inflammatory Memory of Stem Cells' – New Insights for Hematologic Diseases
-
Sep 17, 2025, 16:32Endovascular Today: Dr. Eric Secemsky Analyzes Impact of Paclitaxel Pause on Peripheral Artery Disease Care
-
Sep 17, 2025, 16:28Haemnet Showcases Research on Severe Haemophilia A Patients Adapting to Emicizumab Therapy
-
Sep 17, 2025, 16:19Todd Villines: Coronary Artery Disease - A BIG Movement to Change
-
Sep 16, 2025, 14:59A New Era in Antiplatelet Therapy for CABG?
-
Sep 16, 2025, 07:44Artificial Blood Breakthrough in Japan: Long Shelf Life, No Type Matching, and a Purple Future
-
Sep 16, 2025, 02:44Wolfgang Miesbach Highlights First Inhibitor Case After Hemophilia A Gene Therapy (Giroctocogene Fitelparvovec)
-
Sep 12, 2025, 15:21Christian Schäfer: INR Self-Management Has Officially Been Given Class IA Status in the ESC Guidelines
-
Sep 9, 2025, 20:15Linking a Single Dominant Antibody to HIT: A Novel Study Led by Ishac Nazy, Donald Arnold, and John G. Kelton
-
Sep 18, 2025, 06:34'A New Era in Mechanical Thrombectomy?' – Sripal Bangalore Highlights SYMPHONY-PE IDE Study
-
Sep 17, 2025, 10:49Living with Glanzmann Thrombasthenia․ Eliza VanZweden’s Story of Resilience and Advocacy
-
Sep 17, 2025, 10:22Abdul Mannan: Turning Medical Podcasts into Active Learning with Structured Tools
-
Sep 17, 2025, 09:43Global Blood Supply Under Threat: David McIntosh Calls for Action to Support Transfusion Services
-
Sep 17, 2025, 09:08Coronary Arteries, Pericardial Cavity, and the Hidden Danger of Cardiac Tamponade During PCI-By Ahmed Ata